Results 21 to 30 of about 4,369,422 (307)
Progress and Comment on Immunotherapy of Advanced Renal Cell Carcinoma
Zhongliu Fangzhi Yanjiu, 2020 Immunotherapy has made great progress in the treatment of advanced renal cell carcinoma (RCC), since nivolumab was approved for the second-line therapy of advanced RCC.
ZHOU Li, SHENG Xi'nan
doaj +1 more source
Direct observation of tRNA-chaperoned folding of a dynamic mRNA ensemble
Nature Communications, 2023 T-box riboswitches are multi-domain noncoding RNAs that surveil individual amino acid availabilities in most Gram-positive bacteria. T-boxes directly bind specific tRNAs, query their aminoacylation status to detect starvation, and feedback control the ...
Krishna C. Suddala +6 more
doaj +1 more source
Analysis of the Outcomes of Transarterial Chemoembolization as a Bridge Therapy to Liver Transplant for Hepatocellular Carcinomas: a Single-Centered Retrospective Study [PDF]
Journal of Sharif Medical & Dental College, 2022 Objective: To determine the outcomes of transarterial chemoembolization (TACE) as a bridging therapy to liver transplant for Barcelona clinic liver cancer (BCLC) stage A hepatocellular carcinoma.
Huma Hussain +4 more
doaj
miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5
Cancer Cell International, 2021 Background miR-198 is involved in the formation, migration, invasion, and metastasis of various malignant cancers. However, the function and mechanism of action of miR-198 in the tumorigenesis of renal cell carcinoma (RCC) remain elusive.
Chao Yuan +16 more
doaj +1 more source
Journal of Lipid Research, 2010 Farnesoid X receptor (FXR) is a nuclear receptor that regulates genes involved in synthesis, metabolism, and transport of bile acids and thus plays a major role in maintaining bile acid homeostasis.
Joo-Youn Cho +7 more
doaj +1 more source
Basic Research in Kidney Cancer [PDF]
European Urology, 2011 AbstractContextAdvances in basic research will enhance prognosis, diagnosis, and treatment of renal cancer patients.ObjectiveTo discuss advances in our understanding of the molecular basis of renal cancer, targeted therapies, renal cancer and immunity, and genetic factors and renal cell carcinoma (RCC).Evidence acquisitionData on recently published ...
Pouliot, Frederic +9 more
openaire +4 more sources
The Year in Review for Renal Cancer [PDF]
, 2020 The treatment of kidney cancer has made some remarkable strides over the last few years. Two regimens received Food and Drug Administration (FDA) approval, multiple biomarkers were reported to show promise, and further enhancement and refinement of the ...
Vaishampayan, Ulka
core +1 more source
Atypical splicing variants in PKD1 explain most undiagnosed typical familial ADPKD
npj Genomic Medicine, 2023 Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic cause of kidney failure and is primarily associated with PKD1 or PKD2. Approximately 10% of patients remain undiagnosed after standard genetic testing.
Yvonne Hort +12 more
doaj +1 more source
Cancer of a Movable Kidney [PDF]
The American Journal of the Medical Sciences, 1898 n ...
openaire +2 more sources
Case Reports in Transplantation, 2016 Carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in solid organ transplant recipients are associated with high morbidity and mortality. We report a case of a fatal donor-derived CR-KP infection in a combined kidney-pancreas transplant. Given
Giovanni Varotti +5 more
doaj +1 more source